Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323644620> ?p ?o ?g. }
- W4323644620 abstract "<sec> <title>BACKGROUND</title> Over 90% of patients with cancer experience 1 or more symptoms caused directly by cancer or its treatment. These symptoms negatively impact on the completion of planned treatment as well as patients’ health-related quality of life (HRQoL). It often results in serious complications and even life-threatening outcomes. Thus, it has been recommended that surveillance of symptom burden should be performed and managed during cancer treatment. However, differences in symptom profiles in various patients with cancer have not been fully elucidated for use in performing surveillance in the real world. </sec> <sec> <title>OBJECTIVE</title> This study aims to evaluate the burden of symptoms in patients with various types of cancers during chemotherapy or radiation therapy using the PRO-CTCAE (Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events) and its impact on quality of life. </sec> <sec> <title>METHODS</title> We performed a cross-sectional study of patients undergoing outpatient-based chemotherapy, radiation therapy, or both at the National Cancer Center at Goyang or at the Samsung Medical Center in Seoul, Korea between December 2017 and January 2018. To evaluate cancer-specific symptom burden, we developed 10 subsets for using the PRO-CTCAE-Korean. To measure HRQoL, we used the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Participants answered questions prior to their clinic appointments on tablets. Multivariable linear regression was used to analyze symptoms based on cancer type and to evaluate the association between the PRO-CTCAE items and the EORTC QLQ-C30 summary score. </sec> <sec> <title>RESULTS</title> The mean age (SD) of the patients was 55.0 (11.9) years, and 39.94% (540/1352) were male. Overall, symptoms in the gastrointestinal category were the most dominant in all cancers. Fatigue (1034/1352, 76.48%), decreased appetite (884/1352, 65.38%), and numbness and tingling (778/1352, 57.54%) were the most frequently reported. Patients reported more local symptoms caused by a specific cancer. In terms of nonsite-specific symptoms, patients commonly reported concentration (587/1352, 43.42%), anxiety (647/1352, 47.86%), and general pain (605/1352, 44.75%). More than 50% of patients with colorectal (69/127, 54.3%), gynecologic (63/112, 56.3%), breast (252/411, 61.3%), and lung cancers (121/234, 51.7%) experienced decreased libido, whereas 67/112 (59.8%) patients with gynecologic cancer and lymphoma/myeloma reported pain during sexual intercourse. Patients with breast, gastric, and liver cancers were more likely to have the hand-foot syndrome. Worsening PRO-CTCAE scores were associated with poor HRQoL (eg, fatigue: coefficient –8.15; 95% CI –9.32 to –6.97), difficulty in achieving and maintaining erection (coefficient –8.07; 95% CI –14.52 to –1.61), poor concentration (coefficient –7.54; 95% CI –9.06 to –6.01), and dizziness (coefficient –7.24; 95% CI –8.92 to –5.55). </sec> <sec> <title>CONCLUSIONS</title> The frequency and severity of symptoms differed by cancer types. Higher symptom burden was associated with poor HRQoL, which suggests the importance of appropriate surveillance of PRO symptoms during cancer treatment. Considering patients had comprehensive symptoms, it is necessary to include a holistic approach in the symptom monitoring and management strategies based on comprehensive patient-reported outcome measurements. </sec>" @default.
- W4323644620 created "2023-03-10" @default.
- W4323644620 creator A5005727794 @default.
- W4323644620 creator A5012094835 @default.
- W4323644620 creator A5012179152 @default.
- W4323644620 creator A5032088387 @default.
- W4323644620 creator A5041259408 @default.
- W4323644620 creator A5052332702 @default.
- W4323644620 creator A5059881624 @default.
- W4323644620 creator A5062365108 @default.
- W4323644620 creator A5074809202 @default.
- W4323644620 date "2022-11-07" @default.
- W4323644620 modified "2023-09-26" @default.
- W4323644620 title "Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study (Preprint)" @default.
- W4323644620 cites W1490493239 @default.
- W4323644620 cites W1842042263 @default.
- W4323644620 cites W1969577451 @default.
- W4323644620 cites W2021005684 @default.
- W4323644620 cites W2022826257 @default.
- W4323644620 cites W2023045600 @default.
- W4323644620 cites W2025493301 @default.
- W4323644620 cites W2027779936 @default.
- W4323644620 cites W2063933094 @default.
- W4323644620 cites W2070080909 @default.
- W4323644620 cites W2072798105 @default.
- W4323644620 cites W2086148078 @default.
- W4323644620 cites W2101102557 @default.
- W4323644620 cites W2102851966 @default.
- W4323644620 cites W2103322594 @default.
- W4323644620 cites W2113464761 @default.
- W4323644620 cites W2121288264 @default.
- W4323644620 cites W2123667342 @default.
- W4323644620 cites W2137971505 @default.
- W4323644620 cites W2141860845 @default.
- W4323644620 cites W2150540741 @default.
- W4323644620 cites W2158960952 @default.
- W4323644620 cites W2167243645 @default.
- W4323644620 cites W2176241602 @default.
- W4323644620 cites W2238083898 @default.
- W4323644620 cites W2328166755 @default.
- W4323644620 cites W2339024595 @default.
- W4323644620 cites W2530265640 @default.
- W4323644620 cites W2807847564 @default.
- W4323644620 cites W2922928465 @default.
- W4323644620 cites W2975834093 @default.
- W4323644620 cites W2983981789 @default.
- W4323644620 cites W3004872303 @default.
- W4323644620 cites W3011992252 @default.
- W4323644620 cites W3014224733 @default.
- W4323644620 cites W3082740717 @default.
- W4323644620 cites W3084045003 @default.
- W4323644620 cites W3109190131 @default.
- W4323644620 cites W3110120874 @default.
- W4323644620 cites W3125726074 @default.
- W4323644620 cites W3202048886 @default.
- W4323644620 cites W3203819569 @default.
- W4323644620 cites W4225529913 @default.
- W4323644620 doi "https://doi.org/10.2196/preprints.44105" @default.
- W4323644620 hasPublicationYear "2022" @default.
- W4323644620 type Work @default.
- W4323644620 citedByCount "0" @default.
- W4323644620 crossrefType "posted-content" @default.
- W4323644620 hasAuthorship W4323644620A5005727794 @default.
- W4323644620 hasAuthorship W4323644620A5012094835 @default.
- W4323644620 hasAuthorship W4323644620A5012179152 @default.
- W4323644620 hasAuthorship W4323644620A5032088387 @default.
- W4323644620 hasAuthorship W4323644620A5041259408 @default.
- W4323644620 hasAuthorship W4323644620A5052332702 @default.
- W4323644620 hasAuthorship W4323644620A5059881624 @default.
- W4323644620 hasAuthorship W4323644620A5062365108 @default.
- W4323644620 hasAuthorship W4323644620A5074809202 @default.
- W4323644620 hasConcept C121608353 @default.
- W4323644620 hasConcept C126322002 @default.
- W4323644620 hasConcept C159110408 @default.
- W4323644620 hasConcept C197934379 @default.
- W4323644620 hasConcept C2777793932 @default.
- W4323644620 hasConcept C2779951463 @default.
- W4323644620 hasConcept C509974204 @default.
- W4323644620 hasConcept C512399662 @default.
- W4323644620 hasConcept C71924100 @default.
- W4323644620 hasConceptScore W4323644620C121608353 @default.
- W4323644620 hasConceptScore W4323644620C126322002 @default.
- W4323644620 hasConceptScore W4323644620C159110408 @default.
- W4323644620 hasConceptScore W4323644620C197934379 @default.
- W4323644620 hasConceptScore W4323644620C2777793932 @default.
- W4323644620 hasConceptScore W4323644620C2779951463 @default.
- W4323644620 hasConceptScore W4323644620C509974204 @default.
- W4323644620 hasConceptScore W4323644620C512399662 @default.
- W4323644620 hasConceptScore W4323644620C71924100 @default.
- W4323644620 hasLocation W43236446201 @default.
- W4323644620 hasOpenAccess W4323644620 @default.
- W4323644620 hasPrimaryLocation W43236446201 @default.
- W4323644620 hasRelatedWork W2098672846 @default.
- W4323644620 hasRelatedWork W2233648844 @default.
- W4323644620 hasRelatedWork W2622256164 @default.
- W4323644620 hasRelatedWork W3031099491 @default.
- W4323644620 hasRelatedWork W3031152052 @default.
- W4323644620 hasRelatedWork W3043620221 @default.
- W4323644620 hasRelatedWork W3043650857 @default.
- W4323644620 hasRelatedWork W3091031604 @default.